立体定向体部放疗与常规放疗在骨转移镇痛中的比较:系统综述与meta分析
该系统综述与meta分析纳入6项随机对照试验、1项前瞻性队列研究和3项回顾性观察研究,比较立体定向体部放疗(SBRT)与常规放疗(cRT)对骨转移患者的镇痛效果。汇总所有研究及仅随机对照试验的分析均显示,SBRT在3个月和6个月的总缓解率及完全缓解率方面优于cRT。亚组分析提示,照射脊柱病灶、平均生物有效剂量(BED)差异较小或采用调强放疗实施SBRT时,SBRT的镇痛优势更明显。
要点
- 汇总所有研究:SBRT在3个月和6个月的总缓解率均高于cRT(P < .001和P = .015)。
- 仅随机对照试验:SBRT在3个月和6个月的总缓解率及完全缓解率均高于cRT。
- 亚组分析提示,脊柱病灶照射、平均BED差异较小或调强放疗实施SBRT时,SBRT镇痛优势更明显。
核心结论
- BED过度升高可能削弱SBRT的镇痛效果。
- 采用调强放疗实施的SBRT是脊柱寡转移镇痛的优选方式。
- 需要更多随机对照试验来确定SBRT最合适的BED或剂量方案。
研究设计与样本
- 系统综述与meta分析,检索比较SBRT与cRT治疗骨转移的临床试验和观察性研究。
- 纳入6项随机对照试验、1项前瞻性队列研究和3项回顾性观察研究。
- 2004年至2019年间,448例患者接受SBRT,445例患者接受cRT。
- 所有前瞻性研究将病灶定义为寡转移。
- 存在显著异质性时采用随机效应模型,否则采用固定效应模型;先分析所有纳入研究,再仅分析随机对照试验。
主要发现
- 基于所有纳入研究的汇总结果:SBRT与更高的总缓解率相关(3个月P < .001;6个月P = .015)。
- 基于所有纳入研究的汇总结果:SBRT与更高的完全缓解率相关(1个月P = .029;6个月P < .001)。
- 基于随机对照试验的汇总结果:3个月和6个月SBRT与更高的总缓解率相关(分别为P < .001和P = .017)。
- 基于随机对照试验的汇总结果:3个月和6个月SBRT与更高的完全缓解率相关(分别为P < .001和P < .00)。
- 亚组分析提示,在更多情况下,照射脊柱病灶、平均BED差异较小或采用调强放疗实施SBRT时,SBRT的镇痛优势更明显。
关键数值与推荐
- 主要终点为放疗后疼痛缓解;次要终点为疼痛评分变化、局部无进展生存、再照射率和毒性事件。
- 所有前瞻性研究将病灶定义为寡转移。
- 基于所有纳入研究:SBRT组总缓解率在3个月P < .001、6个月P = .015;完全缓解率在1个月P = .029、6个月P < .001。
- 基于随机对照试验:SBRT组总缓解率在3个月P < .001、6个月P = .017;完全缓解率在3个月P < .001、6个月P < .00。
临床怎么用
- 作者认为BED过度升高可能削弱SBRT的镇痛效果。
- 作者认为采用调强放疗实施的SBRT是脊柱寡转移镇痛的优选方式。
- 作者指出需要更多随机对照试验来确定SBRT最合适的BED或剂量方案。
局限性
- 需要更多随机对照试验来确定SBRT最合适的BED或剂量方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to investigate the difference in pain relief between stereotactic body radiation therapy (SBRT) and conventional radiation therapy (cRT) for patients with bone metastases. METHODS AND MATERIALS: Clinical trials and observational studies comparing SBRT versus cRT for bone metastases were retrieved. The main endpoint was pain relief after radiation therapy; the secondary endpoints were pain score change, local progression-free survival, reirradiation rate, and toxic events. When there was a significant heterogeneity, the random-effects model was applied. Otherwise, the fixed-effects model was used. Analyses of all included studies were performed first, followed by analyses of randomized controlled trials (RCTs) only. RESULTS: Six RCTs, 1 prospective cohort study, and 3 retrospective observational studies were enrolled. Between 2004 and 2019, 448 patients received SBRT, and 445 patients received cRT. All prospective studies defined the lesions as oligometastatic. Pooled results based on all included studies indicated that SBRT was generally associated with a higher overall relief rate (P < .001 at 3 months; P = .015 at 6 months) and complete relief rate (P = .029 at 1 month; P < .001 at 6 months). Pooled results based on RCTs indicated that at 3 and 6 months, SBRT was associated with a higher overall relief rate (P < .001 and P = .017, respectively) and complete relief rate (P < .001 and P < .00, respectively). Subgroup analyses indicated that in more cases, the analgesic advantage of SBRT was more obvious when spinal lesions were irradiated, when the difference in the mean biological effective dose (BED) was less, or when intensity modulated radiation therapy was used to deliver SBRT. CONCLUSIONS: Excessive elevation of BED introduces the risk of diminishing the analgesic effect of SBRT. SBRT delivered using intensity modulated radiation therapy is preferred for pain relief in spinal oligometastases. More RCTs are required to determine the most appropriate BED or dose regimen for SBRT.
引用
- Song X, Wei J, Sun R, et al. Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Pain Relief for Bone Metastases: A Systematic Review and Meta-Analysis. Int J Radiat Oncol Biol Phys. 2022. PMID: 36273520. doi:10.1016/j.ijrobp.2022.10.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。